Tvardi Therapeutics, Inc. (TVRD)
NASDAQ: TVRD · Real-Time Price · USD
4.000
0.00 (0.00%)
At close: May 18, 2026, 4:00 PM EDT
3.900
-0.100 (-2.50%)
Pre-market: May 19, 2026, 4:32 AM EDT
Tvardi Therapeutics Market Cap
Tvardi Therapeutics has a market cap or net worth of $37.53 million as of May 19, 2026. Its market cap has decreased by -84.99% in one year.
Market Cap
37.53M
Enterprise Value
12.72M
1-Year Change
-84.99%
Ranking
Category
Stock Price
$4.00
Market Cap Chart
Since April 16, 2025, Tvardi Therapeutics's market cap has decreased from $170.73M to $37.53M, a decrease of -78.02%. That is a compound annual growth rate of -75.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 18, 2026 | 37.53M | -6.98% |
| Dec 31, 2025 | 40.34M | -76.37% |
| Apr 16, 2025 | 170.73M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| INmune Bio | 41.21M |
| Quantum BioPharma | 39.31M |
| Actinium Pharmaceuticals | 38.97M |
| Mereo BioPharma Group | 38.55M |
| RenovoRx | 36.94M |
| Plus Therapeutics | 36.03M |
| Aligos Therapeutics | 35.33M |
| Lantern Pharma | 35.20M |